Inhibition of GLI Transcriptional Activity and Prostate Cancer Cell Growth and Proliferation by DAX1
Open Access
- 27 June 2023
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 45 (7) , 5347-5361
Abstract
The Hedgehog (Hh) signaling pathway plays an essential role in the initiation and progression of prostate cancer. This is mediated by transcriptional factors belonging to the GLI (glioma-associated oncogene) family, which regulate downstream targets to drive prostate cancer progression. The activity of GLI proteins is tightly controlled by a range of mechanisms, including molecular interactions and post-translational modifications. In particular, mitogenic and oncogenic signaling pathways have been shown to regulate GLI protein activity independently of upstream Hh pathway signaling. Identifying GLI protein regulators is critical for the development of targeted therapies that can improve patient outcomes. This study aimed to identify a novel protein that directly regulates the activity of GLI transcription factors in prostate cancer. We performed gene expression, cellular analyses, and reporter assays to demonstrate that DAX1 (dosage-sensitive sex reversal adrenal hypoplasia congenital critical region on X chromosome, gene 1) interacts with GLI1 and GLI2, the master regulators of Hh signaling. Interestingly, DAX1 overexpression significantly inhibited Hh signaling by reducing GLI1 and GLI2 activity, prostate cancer cell proliferation, and viability. Our results shed light on a novel regulatory mechanism of Hh signaling in prostate cancer cells. The interaction between DAX1 and GLI transcription factors provides insight into the complex regulation of Hh signaling in prostate cancer. Given the importance of Hh signaling in prostate cancer progression, targeting DAX1–GLI interactions may represent a promising therapeutic approach against prostate cancer. Overall, this study provides new insights into the regulation of the Hh pathway and its role in prostate cancer progression. The findings suggest that DAX1 could serve as a potential therapeutic target for the treatment of prostate cancer.Keywords
Funding Information
- Incheon National University Research (2016)
This publication has 31 references indexed in Scilit:
- Hedgehog Signaling in Prostate Cancer and Its Therapeutic ImplicationInternational Journal of Molecular Sciences, 2013
- Orphan Nuclear Receptor DAX-1 Acts as a Novel Corepressor of Liver X Receptor α and Inhibits Hepatic LipogenesisJournal of Biological Chemistry, 2010
- Context-dependent Regulation of the GLI Code in Cancer by HEDGEHOG and Non-HEDGEHOG SignalsJournal of Molecular Cell Biology, 2010
- Non-consensus GLI binding sites in Hedgehog target gene regulationBMC Molecular Biology, 2010
- DAX-1 Acts as a Novel Corepressor of Orphan Nuclear Receptor HNF4α and Negatively Regulates Gluconeogenic Enzyme Gene ExpressionJournal of Biological Chemistry, 2009
- LXXLL motifs and AF-2 domain mediate SHP (NR0B2) homodimerization and DAX1 (NR0B1)–DAX1A heterodimerizationMolecular Genetics and Metabolism, 2007
- Inhibition of GLI1 gene activation by Patched1Biochemical Journal, 2006
- Molecular mechanisms of DAX1 actionMolecular Genetics and Metabolism, 2004
- Hedgehog signaling in animal development: paradigms and principlesGenes & Development, 2001
- Biochemical evidence that Patched is the Hedgehog receptorNature, 1996